Research Article
Obesity and Prognostic Variables in Colombian Breast Cancer Patients: A Cross-Sectional Study
Table 3
BMI and tumor histopathologic features in premenopausal Colombian breast cancer patients.
| Tumor characteristics | BMI | Normal | Overweight | Obese | value |
| Tumor size , (%) | | | | | TX | 5 (2.9) | 4 (2.3) | 2 (1.5) | 0.821 | T1 | 45 (26.0) | 39 (22.2) | 26 (19.7) | T2 | 60 (34.7) | 59 (33.5) | 52 (39.4) | T3 | 31 (17.9) | 39 (22.2) | 23 (17.4) | T4 | 32 (18.5) | 35 (19.9) | 29 (22.0) |
| Lymph nodes , (%) | | | | | Nx | 66 (13.7) | 53 (11) | 42 (8.7) | 0.412 | N0 | 57 (11.8) | 70 (14.5) | 55 (11.4) | N1–N3 | 50 (10.4) | 53 (11) | 35 (7.2) |
| TNM (%) | | | | | I | 35 (7.2) | 34 (7.0) | 22 (4.5) | 0.847 | II | 83 (17.26) | 86 (17.8) | 68 (14.1) | III | 42 (8.7) | 49 (10.1) | 37 (7.6) | IV | 8 (1.66) | 4 (0.8) | 3 (0.6) |
| Tumor grade | | | | | G1 | 36 (20.6) | 30 (17.1) | 17 (13.0) | 0.142 | G2 | 69 (39.4) | 83 (47.4) | 61 (46.6) | G3 | 41 (23.5) | 45 (25.7) | 40 (30.5) |
| Estrogen receptor status | | | | | Positive | 132 (75.4) | 121 (69.1) | 83 (63.4) | 0.072 | Negative | 43 (24.6) | 54 (30.9) | 48 (36.6) |
| Progesterone receptor status | | | | | Positive | 122 (69.7) | 111 (63.4) | 73 (55.7) | 0.042 | Negative | 53 (30.3) | 64 (36.6) | 58 (44.3) |
| HER2 status, (%) | | | | | Negative | 123 (71.1) | 115 (65.3) | 95 (72.0) | 0.384 | Positive | 42 (24.3) | 54 (30.7) | 35 (26.5) | Unknown | 8 (4.6) | 7(4.0) | 2 (1.5) |
| Molecular subtype (IHC4) | | | | | Luminal A | 61 (34.9) | 57 (32.6) | 43 (32.8) | 0.397 | Luminal B, HER 2− | 38 (21.8) | 32 (18.3) | 21 (16.0) | Luminal B, HER 2+ | 30 (17.1) | 33 (18.9) | 19 (14.5) | Her2-enriched | 13 (7.4) | 20 (11.4) | 16 (12.2) | Triple negative | 25 (14.3) | 26 (14.9) | 30 (22.9) |
|
|